FDA Clears Path for Generic NUTRACORT Hydrocortisone Gel Approvals
Published Date: 9/3/2025
Notice
Summary
The FDA says NUTRACORT hydrocortisone gel, 1%, wasn’t taken off the market because of safety or effectiveness problems. This means drug companies can now get approval to sell generic versions, as long as they follow the rules. People who use or make this gel can expect more options soon, with no extra costs or delays.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Generic Approvals Allowed for NUTRACORT 1%
If you use NUTRACORT (hydrocortisone) topical gel, 1%, the FDA has determined it was not withdrawn for reasons of safety or effectiveness. That determination lets drugmakers seek approval of abbreviated new drug applications (ANDAs) for NUTRACORT (hydrocortisone) topical gel, 1%, if they meet all other legal and regulatory requirements.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Previous / Next Documents
Previous: 2025-16862, Southern International Co., Ltd., Complainant v. Daynamez Group of Companies LLC, Respondent; Notice of Filing of Complaint and Assignment
Southern International Co., Ltd. is suing Daynamez Group of Companies LLC for not paying shipping fees on 558 containers and misusing funds. This case is now with the Federal Maritime Commission, and Daynamez has 25 days to respond. A judge’s decision is expected by August 31, 2026, with a final ruling by March 15, 2027, which could impact both companies financially.
Next: 2025-16864, Taking and Importing Marine Mammals; Taking Marine Mammals Incidental to Geophysical Surveys in the Gulf of America
The government is considering bringing back rules that protect marine mammals during underwater surveys in the Gulf of America. These surveys can accidentally disturb whales and dolphins, so the rules help keep them safe. People have a chance to share their thoughts before any decisions are made, and this could affect survey activities soon.